The Efficacy of Adalimumab in Children with Chronic Non-infectious Posterior Uveitis and Panuveitis: A Retrospective Cohort Study.
Tianyu TaoShizhao YangDaquan HeXuening PengZhenyu WangQi JiangTianfu WangWenru SuPublished in: Ophthalmology and therapy (2024)
Adalimumab was effective in the treatment of chronic noninfectious posterior uveitis and panuveitis in pediatric patients, and disease inactivity was accomplished in the majority of the patients, thereby improving visual outcomes and maintaining disease stability. Adverse events were limited and tolerable.
Keyphrases
- juvenile idiopathic arthritis
- end stage renal disease
- rheumatoid arthritis
- newly diagnosed
- ankylosing spondylitis
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- ulcerative colitis
- metabolic syndrome
- disease activity
- adipose tissue
- systemic lupus erythematosus
- skeletal muscle
- patient reported outcomes
- insulin resistance